Security key
552641102
MAIA Biotechnology, Inc. - Common Stock, $0.0001 par value per share (MAIA)
CUSIP: 552641102
Q4 2023 13F Holders as of 31 Dec 2023
- Type / Class
- Equity / Common Stock, $0.0001 par value per share
- Shares outstanding
- 60,521,183
- Total 13F shares
- 803,162
- Share change
- +484,884
- Total reported value
- $957,759
- Price per share
- $1.17
- Number of holders
- 21
- Value change
- +$550,428
- Number of buys
- 17
- Number of sells
- 2
Report period
Q4 2023
Institutions
21
Top holders
10
MAIA full security history
Newer quarter: Q1 2024
Previous quarter: Q3 2023
MAIA Biotechnology, Inc. SEC filings
MAIA Biotechnology, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 552641102
Recent filing periods:
Top shareholders of MAIA - MAIA Biotechnology, Inc. - Common Stock, $0.0001 par value per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Sergei M. Gryaznov |
13D/G
|
— |
4.1%
|
1,140,115
|
$2,394,242 | $0 | 31 Dec 2023 | |
| VANGUARD GROUP INC |
13F
|
Company |
0.15%
|
93,500
|
$205,700 | — | 30 Sep 2023 | |
| Centric Wealth Management |
13F
|
Company |
0.11%
|
64,656
|
$142,243 | — | 30 Sep 2023 | |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.09%
|
51,600
|
$113,520 | — | 30 Sep 2023 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.07%
|
44,557
|
$98,065 | — | 30 Sep 2023 | |
| Naviter Wealth, LLC |
13F
|
Company |
0.04%
|
22,168
|
$48,770 | — | 30 Sep 2023 | |
| FNY Investment Advisers, LLC |
13F
|
Company |
0.03%
|
17,550
|
$38,000 | — | 30 Sep 2023 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0.02%
|
13,972
|
$30,739 | — | 30 Sep 2023 | |
| MORGAN STANLEY |
13F
|
Company |
0.01%
|
5,095
|
$11,209 | — | 30 Sep 2023 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0.01%
|
4,923
|
$10,831 | — | 30 Sep 2023 | |
| UBS Group AG |
13F
|
Company |
0%
|
133
|
$293 | — | 30 Sep 2023 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0%
|
63
|
$139 | — | 30 Sep 2023 | |
| Sunbelt Securities, Inc. |
13F
|
Company |
0%
|
50
|
$110 | — | 30 Sep 2023 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0%
|
11
|
$24 | — | 30 Sep 2023 | |
| Mihail Obrocea |
3/4/5
|
Chief Medical Officer |
—
class O/S missing
|
87,495
|
— | — | 31 May 2023 | |
| Joseph F. McGuire |
3/4/5
|
Chief Financial Officer |
—
class O/S missing
|
69,075
|
— | — | 31 May 2023 | |
| Laurentiu Vlad |
3/4/5
|
Director |
—
class O/S missing
|
3,045
|
— | — | 30 Dec 2022 |
Institutional Holders of MAIA Biotechnology, Inc. - Common Stock, $0.0001 par value per share (MAIA) as of Q4 2023
As of 31 Dec 2023,
MAIA Biotechnology, Inc. - Common Stock, $0.0001 par value per share (MAIA) was held by
21 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
803,162 shares.
The largest 10 holders included
VANGUARD GROUP INC, SABBY MANAGEMENT, LLC, RENAISSANCE TECHNOLOGIES LLC, BRIDGEWAY CAPITAL MANAGEMENT, LLC, Centric Wealth Management, CITADEL ADVISORS LLC, GEODE CAPITAL MANAGEMENT, LLC, XTX Topco Ltd, Naviter Wealth, LLC, and STATE STREET CORP.
This page lists
21
institutional shareholders reporting positions in this security
for the Q4 2023 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2023 vs Q3 2023 Across Filers
Q3 2023 holders
13
Q4 2023 holders
21
Holder diff
8
| Investor | Q3 2023 Shares | Q4 2023 Shares | Share Diff | Share Chg % | Q3 2023 Value $ | Q4 2023 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.